{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:58:06Z","timestamp":1792627086216,"version":"4.5.0"},"reference-count":222,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["BMS\/ADHOC\/SCR-0391\/Nov14\/17\/KA\/PVT"],"award-info":[{"award-number":["BMS\/ADHOC\/SCR-0391\/Nov14\/17\/KA\/PVT"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.autrev.2025.103841","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:50:45Z","timestamp":1748919045000},"page":"103841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Genetic and immune dysregulation in vitiligo: Insights into autoimmune mechanisms and disease pathogenesis"],"prefix":"10.1016","volume":"24","author":[{"given":"Sathvik","family":"Upadhya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa J","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapaettu","family":"Satyamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jdermsci.2005.06.004","article-title":"The genetic concept of vitiligo","volume":"39","author":"Zhang","year":"2005","journal-title":"J Dermatol Sci"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo A comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103841_bb0015","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kruger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2025.103841_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/0378-6323.19730","article-title":"Vitiligo A sign of systemic disease","volume":"72","author":"Huggins","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaad.2003.12.044","article-title":"Characteristics of genetic epidemiology and genetic models for vitiligo","volume":"51","author":"Zhang","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1034\/j.1600-0749.2001.140608.x","article-title":"\u2018VIT1\u2019, a novel gene associated with vitiligo","volume":"14","author":"Le Poole","year":"2001","journal-title":"Pigment Cell Res"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/eci.11.88","article-title":"Etiology of autoimmune disease past, present and future","volume":"8","author":"Alzabin","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103841_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaut.2013.06.004","article-title":"Promotion and prevention of autoimmune disease by CD8+ T cells","volume":"45","author":"Gravano","year":"2013","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0045","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1080\/13685538.2020.1806814","article-title":"Levels of TNF-alpha, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo","volume":"23","author":"Karagun","year":"2020","journal-title":"Aging Male"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0055","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/JLB.5A0122-027R","article-title":"In vitro-induced Foxp3(+) CD8(+) regulatory T cells suppress allergic IgE response in the gut","volume":"112","author":"Giri","year":"2022","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigm Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2025.103841_bb0065","series-title":"Vitiligo: a review","author":"Bergqvist","year":"2011"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11154-018-9450-7","article-title":"Thyroid diseases and skin autoimmunity","volume":"19","author":"Baldini","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"issue":"5 Pt 1","key":"10.1016\/j.autrev.2025.103841_bb0075","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0190-9622(86)70260-0","article-title":"Correlation between vitiligo antibodies and extent of depigmentation in vitiligo","volume":"15","author":"Naughton","year":"1986","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo Implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0923-1811(92)90017-6","article-title":"Genetic nature of vitiligo","volume":"4","author":"Bhatia","year":"1992","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2025.103841_bb0095","series-title":"Genetic epidemiology of vitiligo multilocus recessivity cross-validated","author":"Nath","year":"1994"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2025.103841_bb0110","series-title":"The genetic architecture of vitiligo","first-page":"8","author":"Roberts","year":"2020"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0115","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat Genet"},{"issue":"FEB","key":"10.1016\/j.autrev.2025.103841_bb0120","article-title":"Genetic susceptibility to vitiligo GWAS approaches for identifying vitiligo susceptibility genes and loci","volume":"7","author":"Shen","year":"2016","journal-title":"Front Genet"},{"key":"10.1016\/j.autrev.2025.103841_bb0125","series-title":"Genetics of vitiligo","first-page":"245","author":"Spritz","year":"2017"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103841_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/9780470760116.ch17","article-title":"17 autocytotoxic hypothesis for the destruction of melanocytes as the cause of Vitiligo","volume":"137","author":"Hann","year":"2000","journal-title":"Vitiligo"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0140","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/bjd.15151","article-title":"Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo","volume":"176","author":"Kim","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0145","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/pcmr.12402","article-title":"Use of permanent hair dyes and risk of vitiligo in women","volume":"28","author":"Wu","year":"2015","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0150","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/jid.2011.16","article-title":"Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy","volume":"131","author":"van den Boorn","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0625.1993.tb00023.x","article-title":"Review of the etiopathomechanism of vitiligo a convergence theory","volume":"2","author":"Le Poole","year":"1993","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/exd.13677","article-title":"The convergence theory for vitiligo A reappraisal","volume":"28","author":"Kundu","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2025.103841_bb0165","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3389\/fimmu.2019.00856","article-title":"The emerging epigenetic role of CD8+T cells in autoimmune diseases a systematic review","volume":"10","author":"Deng","year":"2019","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0170","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/bjd\/ljae472","article-title":"The emerging role of regulatory T cells in the immunopathogenesis of vitiligo and implications for treatment","volume":"192","author":"Liu","year":"2025","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250281","article-title":"The IFN-gamma-CXCL9\/CXCL10-CXCR3 axis in vitiligo Pathological mechanism and treatment","volume":"54","author":"Liu","year":"2024","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2025.103841_bb0180","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103841_bb0185","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"Van Den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"9988","key":"10.1016\/j.autrev.2025.103841_bb0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0195","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/jid.2013.540","article-title":"A quantitative increase in regulatory T cells controls development of vitiligo","volume":"134","author":"Chatterjee","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0200","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","article-title":"Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice","volume":"184","author":"Gregg","year":"2010","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103841_bb0205","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00262-011-0984-8","article-title":"Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice","volume":"60","author":"Amos","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","article-title":"Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3","volume":"138","author":"Boniface","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0220","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaad.2008.09.048","article-title":"The role of helper and regulatory T cells in the pathogenesis of vitiligo","volume":"60","author":"Basak","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.autrev.2006.10.002","article-title":"Autoimmune inflammation from the Th17 perspective","volume":"6","author":"Furuzawa-Carballeda","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0230","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2340\/00015555-2080","article-title":"Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes a pivotal role of CD8+ cytotoxic T lymphocytes in vitiligo","volume":"95","author":"Yang","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0235","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.1304988111","article-title":"IFN-\u03b3 signaling maintains skin pigmentation homeostasis through regulation of melanosome maturation","volume":"111","author":"Natarajan","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"223","key":"10.1016\/j.autrev.2025.103841_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/jocd.12517","article-title":"Cytokine profile (<scp>IL<\/scp>-2, <scp>IL<\/scp>-6, <scp>IL<\/scp>-17, <scp>IL<\/scp>-22, and <scp>TNF<\/scp>-\u03b1) in vitiligo\u2014new insight into pathogenesis of disease","volume":"18","author":"Sushama","year":"2019","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/exd.14053","article-title":"Fas-FasL interaction in cytotoxic T cell-mediated vitiligo The role of lesional expression of tumor necrosis factor-\u03b1 and interferon-\u03b3 in Fas-mediated melanocyte apoptosis","volume":"29","author":"Jimbo","year":"2020","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0255","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res"},{"issue":"8","key":"10.1016\/j.autrev.2025.103841_bb0260","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-4632.2006.02744.x","article-title":"Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo","volume":"45","author":"Birol","year":"2006","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052298","article-title":"Increased tumor necrosis factor (TNF)-\u03b1 and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo","volume":"7","author":"Laddha","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/ced.12464","article-title":"Interleukin-33 affects cytokine production by keratinocytes in vitiligo","volume":"40","author":"Li","year":"2015","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103841_bb0275","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00403-016-1675-2","article-title":"IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo","volume":"308","author":"Vaccaro","year":"2016","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0280","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jdermsci.2013.04.014","article-title":"Expression of IL-33 in the epidermis: the mechanism of induction by IL-17","volume":"71","author":"Meephansan","year":"2013","journal-title":"J Dermatol Sci"},{"issue":"10","key":"10.1016\/j.autrev.2025.103841_bb0285","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00403-012-1277-6","article-title":"Subtoxic levels hydrogen peroxide-induced expression of interleukin-6 by epidermal melanocytes","volume":"304","author":"Yao","year":"2012","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0290","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/08820139.2020.1813756","article-title":"Investigation of the role of Interleukin 6 in vitiligo pathogenesis","volume":"51","author":"Singh","year":"2022","journal-title":"Immunol Investig"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0295","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","article-title":"Role of interleukin-17 in the pathogenesis of vitiligo","volume":"36","author":"Bassiouny","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0300","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2011.07.018","article-title":"Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-beta) in patients with vitiligo","volume":"66","author":"Khan","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2025.103841_bb0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-869-0_1","article-title":"Natural and induced T CD4+CD25+FOXP3+ regulatory T cells","volume":"677","author":"Chatenoud","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103841_bb0310","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/exd.14157","article-title":"Decreased suppression of CD8(+) and CD4(+) T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins","volume":"29","author":"Giri","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2025.103841_bb0315","doi-asserted-by":"crossref","first-page":"6952299","DOI":"10.1155\/2022\/6952299","article-title":"Meta-analysis of alterations in regulatory T cells\u2019 frequency and suppressive capacity in patients with vitiligo","volume":"2022","author":"Giri","year":"2022","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0320","article-title":"Understanding the role of lymphocytes in vitiligo","volume":"8","author":"Sherif","year":"2021","journal-title":"IntJ Immunol Immunother"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/ijd.IJD_344_18","article-title":"Antimelanocyte antibodies a possible role in patients with vitiligo","volume":"65","author":"El-Gayyar","year":"2020","journal-title":"Indian J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0330","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imr.12859","article-title":"The role of B cell antigen presentation in the initiation of CD4+ T cell response","volume":"296","author":"Hua","year":"2020","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0335","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2007.07.012","article-title":"Apoptosis of melanocytes in vitiligo results from antibody penetration","volume":"29","author":"Ruiz-Arguelles","year":"2007","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0340","article-title":"Elevated level of B-cell-activating factor in tissues and serum of patients with vitiligo a proof of autoimmune theory","volume":"16","author":"El-Rifaie","year":"2019","journal-title":"J Egypt Women Dermatol Soc"},{"key":"10.1016\/j.autrev.2025.103841_bb0345","series-title":"Alterations of circulating B cells and follicular helper T cell subsets with low Ig M level in active non-segmental vitiligo","author":"Zhen","year":"2020"},{"key":"10.1016\/j.autrev.2025.103841_bb0350","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.12659\/MSM.910515","article-title":"Identification of the risk HLA-A alleles and autoantigen in Han Chinese vitiligo patients and the association of CD8+T cell reactivity with disease characteristics","volume":"24","author":"Yi","year":"2018","journal-title":"Med Sci Monitor"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0355","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/gepi.1370020303","article-title":"Familial aggregation and genetics","volume":"2","author":"Das","year":"1985","journal-title":"Genet Epidemiol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2020.07.029","article-title":"Familial risk of vitiligo among first-degree relatives and spouses: a population-based cohort study in korea","volume":"141","author":"Kim","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0749.2005.00279.x","article-title":"HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset","volume":"19","author":"Fain","year":"2006","journal-title":"Pigment Cell Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0370","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1038\/s41467-018-06023-5","article-title":"The complex underpinnings of genetic background effects","volume":"9","author":"Mullis","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0375","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jdermsci.2006.08.001","article-title":"MYG1, novel melanocyte related gene, has elevated expression in vitiligo","volume":"44","author":"Kingo","year":"2006","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0380","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-11-56","article-title":"Promoter polymorphism -119C\/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1","volume":"11","author":"Philips","year":"2010","journal-title":"BMC Med Genet"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0385","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0390","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2133.2008.08785.x","article-title":"Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera","volume":"159","author":"R\u00e4tsep","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0395","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.humimm.2012.01.011","article-title":"The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells","volume":"73","author":"Reimann","year":"2012","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0400","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0190-9622(83)80279-5","article-title":"Association of HLA-DR4 with vitiligo","volume":"8","author":"Foley","year":"1983","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0405","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1399-0004.1991.tb02984.x","article-title":"Age of onset in vitiligo relationship with HLA supratypes","volume":"39","author":"Finco","year":"1991","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0410","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2133.1993.tb03167.x","article-title":"Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type","volume":"129","author":"Ando","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2025.103841_bb0415","series-title":"Association of HLA alleles and haplotypes with vitiligo in moroccan patients: a case \u2013 control study","first-page":"925","author":"Bouayad","year":"2013"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0420","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1365-4632.2004.02389.x","article-title":"Association of HLA-DQA1 and DQB1 genes with vitiligo in Chinese Hans","volume":"44","author":"Yang","year":"2005","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0425","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jdermsci.2004.05.003","article-title":"Association of HLA class I alleles with vitiligo in Chinese Hans","volume":"35","author":"Zhang","year":"2004","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11033-021-06855-3","article-title":"Contribution of HLA class II genes, DRB4*01:01, DRB1*07:01, and DQB1*03:03:2 to clinical features of Vitiligo disease in Iranian population","volume":"49","author":"Ghaffarnia","year":"2022","journal-title":"Mol Biol Rep"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0435","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1111\/ijd.13194","article-title":"Association of class I and II HLA alleles and haplotypes with susceptibility to vitiligo a study of patients with vitiligo from southeast Brazil","volume":"55","author":"Ramire","year":"2016","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0440","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14024","article-title":"The relationship between non-segmental Vitiligo, HLA genotype and oxidative stress","volume":"75","author":"Hayran","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0749.2004.00141.x","article-title":"Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population","volume":"17","author":"Tastan","year":"2004","journal-title":"Pigment Cell Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0450","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/jid.2011.240","article-title":"HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo","volume":"132","author":"Singh","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0455","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0165-2478(91)90245-6","article-title":"HLA-DR1 is associated with vitiligo","volume":"27","author":"Poloy","year":"1991","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0460","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/1993\/356874","article-title":"HLA associations in vitiligo patients in the Dutch population","author":"Venneker","year":"1993","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0465","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.2001.04288.x","article-title":"Linkage and association of HLA class II genes with vitiligo in a Dutch population","volume":"145","author":"Zamani","year":"2001","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0470","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0749.2004.00145.x","article-title":"Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study","volume":"17","author":"de Vijlder","year":"2004","journal-title":"Pigment Cell Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0475","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archderm.1990.01670250062009","article-title":"Vitiligo is associated with HLA-DR4 in black patients: a preliminary report","volume":"126","author":"Dunston","year":"1990","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0480","first-page":"13","article-title":"Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo","volume":"8","author":"Buc","year":"1998","journal-title":"Eur J Dermatol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2025.103841_bb0485","first-page":"23","article-title":"Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations","volume":"42","author":"Buc","year":"1996","journal-title":"Folia Biol (Praha)"},{"issue":"7","key":"10.1016\/j.autrev.2025.103841_bb0490","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00403-006-0699-4","article-title":"Association of HLA loci alleles and antigens in Saudi patients with vitiligo","volume":"298","author":"Abanmi","year":"2006","journal-title":"Arch Dermatol Res"},{"issue":"16","key":"10.1016\/j.autrev.2025.103841_bb0495","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/0006-2952(75)90029-5","article-title":"Comparison between procaine and isocarboxazid metabolism in vitro by a liver microsomal amidase-esterase","volume":"24","author":"Moroi","year":"1975","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0500","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1399-0039.1978.tb01349.x","article-title":"HLA antigens and vitiligo in an American black population","volume":"12","author":"Kachru","year":"1978","journal-title":"Tissue Antigens"},{"issue":"18","key":"10.1016\/j.autrev.2025.103841_bb0615","first-page":"1686","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin","year":"2010","journal-title":"SAB Pediatr"},{"key":"10.1016\/j.autrev.2025.103841_bb0680","series-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48(11)","author":"Jin","year":"2016"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0685","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jid.2010.337","article-title":"Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP","volume":"131","author":"Birlea","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103841_bb0690","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ng.602","article-title":"Common variants in FOXP1 are associated with generalized vitiligo","volume":"42","author":"Jin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2025.103841_bb0610","series-title":"Association analyses identify three susceptibility loci for vitiligo in the Chinese Han population 2013","first-page":"403","author":"Tang","year":"2012"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0695","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.2007.13","article-title":"Genetic determinants of hair, eye and skin pigmentation in Europeans","volume":"39","author":"Sulem","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2025.103841_bb0620","series-title":"Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8","author":"Birlea","year":"2010"},{"issue":"7","key":"10.1016\/j.autrev.2025.103841_bb0700","doi-asserted-by":"crossref","DOI":"10.1038\/ng.603","article-title":"Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC","volume":"42","author":"Quan","year":"2010","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0630","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3346\/jkms.2013.28.5.775","article-title":"Three new single nucleotide polymorphisms identified by a genome-wide association study in Korean patients with vitiligo","volume":"28","author":"Cheong","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2025.103841_bb0655","series-title":"The genetics of generalized vitiligo","first-page":"244","author":"Spritz","year":"2008"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0535","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12020-013-9908-z","article-title":"Variants in PTPN22 and SMOC2 genes and the risk of thyroid disease in the Jordanian Arab population","volume":"44","author":"Alkhateeb","year":"2012","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0840","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1373\/clinchem.2010.148221","article-title":"Genetics of type 1 diabetes","volume":"57","author":"Steck","year":"2011","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0850","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jid.2011.321","article-title":"Six decades of vitiligo genetics genome-wide studies provide insights into autoimmune pathogenesis","volume":"132","author":"Spritz","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103841_bb0855","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/gm199","article-title":"The genetics of generalized vitiligo autoimmune pathways and an inverse relationship with malignant melanoma","volume":"2","author":"Spritz","year":"2010","journal-title":"Genome Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0860","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/intimm\/dxw002","article-title":"Genetics of autoimmune diseases perspectives from genome-wide association studies","volume":"28","author":"Kochi","year":"2016","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0505","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1755-148X.2009.00543.x","article-title":"CTLA4 and generalized vitiligo two genetic association studies and a meta-analysis of published data","volume":"22","author":"Birlea","year":"2009","journal-title":"Pigm Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2025.103841_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.mod.2019.05.001","article-title":"The transcription factor Foxp1 regulates the differentiation and function of dendritic cells","volume":"158","author":"Guo","year":"2019","journal-title":"Mech Dev"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0870","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0875","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00281-022-00912-0","article-title":"Genetics of rheumatoid arthritis","volume":"44","author":"Padyukov","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2025.103841_bb0880","article-title":"Genetic association and machine learning improves discovery and prediction of type 1 diabetes","author":"McGrail","year":"2024","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0885","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaci.2021.05.033","article-title":"TSLP disease-associated genetic variants combined with airway TSLP expression influence asthma risk","volume":"149","author":"Murrison","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0735","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ng.249","article-title":"Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci","volume":"40","author":"Cooper","year":"2008","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0895","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.autrev.2025.103841_bb0900","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.gene.6364016","article-title":"Genes of the LMP\/TAP cluster are associated with the human autoimmune disease vitiligo","volume":"4","author":"Casp","year":"2003","journal-title":"Genes Immun"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2025.103841_bb0765","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2119\/molmed.2009.00008","article-title":"Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis","volume":"15","author":"Cui","year":"2009","journal-title":"Mol Med (Cambridge, Mass)"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0905","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/db18-0882","article-title":"Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families","volume":"68","author":"Hippich","year":"2019","journal-title":"Diabetes"},{"issue":"23","key":"10.1016\/j.autrev.2025.103841_bb0910","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1093\/hmg\/dds357","article-title":"Seven newly identified loci for autoimmune thyroid disease","volume":"21","author":"Cooper","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0915","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41419-022-05479-0","article-title":"SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.autrev.2025.103841_bb0920","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ng2102","article-title":"Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes","volume":"39","author":"Lowe","year":"2007","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0925","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4078\/jrd.22.0054","article-title":"The SLC29A3 variant, neutrophilic dermatosis, and hyperferritinemia imitate systemic juvenile idiopathic arthritis in a Saudi child a case report","volume":"30","author":"Alansari","year":"2023","journal-title":"J Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0930","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/ard-2023-224540","article-title":"Expression quantitative trait loci analysis in rheumatoid arthritis identifies tissue specific variants associated with severity and outcome","volume":"83","author":"Goldmann","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103841_bb0935","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1061939","article-title":"Role of the CXCL13\/CXCR5 axis in autoimmune diseases","volume":"13","author":"Pan","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0940","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.902","article-title":"Circulating DNA methylation level of CXCR5 correlates with inflammation in patients with rheumatoid arthritis","volume":"11","author":"Shi","year":"2023","journal-title":"Immun Inflamm Dis"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0945","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0950","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13073-018-0604-8","article-title":"Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations","volume":"10","author":"Marquez","year":"2018","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0955","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s42003-023-05420-x","article-title":"Single-cell chromatin accessibility and transcriptomic characterization of Behcet\u2019s disease","volume":"6","author":"Shi","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.autrev.2025.103841_bb0960","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964891","article-title":"Key molecules associated with thyroid carcinoma prognosis: a study based on transcriptome sequencing and GEO datasets","volume":"13","author":"Bai","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1843","article-title":"A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome","volume":"10","author":"Duis","year":"2022","journal-title":"Mol Genet Genomic Med"},{"issue":"50","key":"10.1016\/j.autrev.2025.103841_bb0970","doi-asserted-by":"crossref","first-page":"88179","DOI":"10.18632\/oncotarget.21165","article-title":"Meta-analysis of the association between NLRP1 polymorphisms and the susceptibility to vitiligo and associated autoimmune diseases","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2025.103841_bb0975","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3389\/fimmu.2018.01197","article-title":"Cytokine secretion and pyroptosis of thyroid follicular cells mediated by enhanced NLRP3, NLRP1, NLRC4, and AIM2 inflammasomes are associated with autoimmune thyroiditis","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103841_bb0980","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.2337\/db08-0753","article-title":"A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3","volume":"57","author":"Concannon","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0985","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000523","article-title":"Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo","volume":"5","author":"Ren","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.autrev.2025.103841_bb0990","doi-asserted-by":"crossref","first-page":"1075813","DOI":"10.3389\/fimmu.2022.1075813","article-title":"The emerging role of regulatory cell-based therapy in autoimmune disease","volume":"13","author":"Ghobadinezhad","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103841_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2022.100084","article-title":"FOXP3 variants are independently associated with transforming growth factor Beta1 plasma levels in female patients with inflammatory bowel disease","volume":"77","author":"Inoue","year":"2022","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0510","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0749.2004.00196.x","article-title":"CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases","volume":"18","author":"Blomhoff","year":"2005","journal-title":"Pigment Cell Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0515","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2133.1999.02610.x","article-title":"Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo","volume":"140","author":"Kemp","year":"1999","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0520","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.smim.2006.03.008","article-title":"Role of PTPN22 in type 1 diabetes and other autoimmune diseases","volume":"18","author":"Bottini","year":"2006","journal-title":"Semin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0525","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3892\/etm.2014.1975","article-title":"Protein tyrosine phosphatase PTPN22 +1858C\/T polymorphism is associated with active vitiligo","volume":"8","author":"Garcia-Melendez","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.autrev.2025.103841_bb0530","series-title":"The PTPN22 -1858C > T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population","author":"Laberge","year":"2008"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0540","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5021\/ad.2014.26.1.88","article-title":"Lack of association between PTPN22 gene +1858 c>t polymorphism and susceptibility to generalized vitiligo in a turkish population","volume":"26","author":"Akbas","year":"2014","journal-title":"Ann Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0545","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1600-0749.2003.00105.x","article-title":"Association of angiotensin converting enzyme gene I\/D polymorphism of vitiligo in Korean population","volume":"17","author":"Jin","year":"2004","journal-title":"Pigment Cell Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0550","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00370723","article-title":"Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes","volume":"287","author":"Grabbe","year":"1994","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"10.1016\/j.autrev.2025.103841_bb0555","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/j.1460-2075.1991.tb07744.x","article-title":"In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development","volume":"10","author":"Nishikawa","year":"1991","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2025.103841_bb0560","series-title":"Human and mouse disorders of pigmentation","first-page":"284","author":"Spritz","year":"2003"},{"issue":"9","key":"10.1016\/j.autrev.2025.103841_bb0565","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/modpathol.3800644","article-title":"Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo","volume":"19","author":"Singh","year":"2006","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0570","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jdermsci.2004.06.008","article-title":"Association of estrogen receptor 1 intron 1 C\/T polymorphism in Korean vitiligo patients","volume":"35","author":"Jin","year":"2004","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2025.103841_bb0575","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.0105-2896.2005.00246.x","article-title":"AIRE and APECED molecular insights into an autoimmune disease","author":"Villase\u00f1or","year":"2005","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0580","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","article-title":"Positional cloning of the APECED gene","volume":"17","author":"Nagamine","year":"1997","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0585","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1297-399","article-title":"An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains","volume":"17","author":"Aaltonen","year":"1997","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb0590","first-page":"591","article-title":"The autoimmune regulator gene (AIRE) is strongly associated with vitiligo","volume":"159","author":"Tazi-Ahnini","year":"2008","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103841_bb0595","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1600-0625.2007.00561.x","article-title":"The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population","volume":"16","author":"Kim","year":"2007","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0600","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.0022-202X.2004.22516.x","article-title":"Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2\u03b1 on melanocyte dendricity","volume":"122","author":"Scott","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0605","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/jid.2012.320","article-title":"Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population","volume":"133","author":"Tang","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0625","first-page":"701","article-title":"SMOC2 gene variant and the risk of vitiligo in Jordanian Arabs","volume":"20","author":"Alkhateeb","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0635","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017046","article-title":"Melanocytes and their diseases","volume":"4","author":"Yamaguchi","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.autrev.2025.103841_bb0640","doi-asserted-by":"crossref","first-page":"2841814","DOI":"10.1155\/2019\/2841814","article-title":"RNA-seq reveals dysregulation of novel melanocyte genes upon oxidative stress implications in vitiligo pathogenesis","volume":"2019","author":"Sastry","year":"2019","journal-title":"Oxidative Med Cell Longev"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0645","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway A promising target for repigmenting vitiligo patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0650","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/jid.2012.37","article-title":"Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation","volume":"132","author":"Jin","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0660","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1751-1097.2011.00970.x","article-title":"Melanocortin 1 receptor variants: functional role and pigmentary associations","volume":"87","author":"Dessinioti","year":"2011","journal-title":"Photochem Photobiol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0665","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdermsci.2007.06.004","article-title":"Gene expression analysis of melanocortin system in vitiligo","volume":"48","author":"Kingo","year":"2007","journal-title":"J Dermatol Sci"},{"issue":"7047","key":"10.1016\/j.autrev.2025.103841_bb0670","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0675","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jmedgenet-2013-102233","article-title":"A comprehensive association analysis confirms ZMIZ1 to be a susceptibility gene for vitiligo in Chinese population","volume":"51","author":"Sun","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.autrev.2025.103841_bb0710","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fgene.2020.542275","article-title":"Validation of susceptibility loci for vitiligo identified by GWAS in the Chinese Han population","volume":"11","author":"Cheng","year":"2020","journal-title":"Front Genet"},{"issue":"7","key":"10.1016\/j.autrev.2025.103841_bb0715","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ng.602","article-title":"Common variants in FOXP1 are associated with generalized vitiligo HHS Public Access Author manuscript","volume":"42","author":"Jin","year":"2010","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.autrev.2025.103841_bb0720","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molmed.2004.05.002","article-title":"The thyroglobulin gene as the first thyroid-specific susceptibility gene for autoimmune thyroid disease","volume":"10","author":"Tomer","year":"2004","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0725","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.leukres.2009.06.029","article-title":"Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia","volume":"34","author":"Mansha","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.autrev.2025.103841_bb0730","series-title":"IL-2 family of cytokines in T regulatory cell development and homeostasis","first-page":"635","author":"Malek","year":"2008"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0740","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002406","article-title":"A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap","volume":"7","author":"Ramos","year":"2011","journal-title":"PLoS Genet"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0745","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ng.582","article-title":"Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci","volume":"42","author":"Stahl","year":"2010","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0750","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2337\/db07-1305","article-title":"A novel susceptibility locus for type 1 diabetes on chr12q13 identified by a genome-wide association study","volume":"57","author":"Hakonarson","year":"2008","journal-title":"Diabetes"},{"issue":"7302","key":"10.1016\/j.autrev.2025.103841_bb0755","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2025.103841_bb0760","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-1326.2008.01003.x","article-title":"MHC fine mapping of human type 1 diabetes using the T1DGC data","volume":"11","author":"He","year":"2009","journal-title":"Diabet Obes Metab"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb0770","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.humimm.2006.02.003","article-title":"Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus","volume":"66","author":"Orozco","year":"2005","journal-title":"Hum Immunol"},{"issue":"26","key":"10.1016\/j.autrev.2025.103841_bb0775","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1056\/NEJMoa0807917","article-title":"Shared and distinct genetic variants in type 1 diabetes and celiac disease","volume":"359","author":"Smyth","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb0780","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng.102","article-title":"Newly identified genetic risk variants for celiac disease related to the immune response","volume":"40","author":"Hunt","year":"2008","journal-title":"Nat Genet"},{"issue":"21","key":"10.1016\/j.autrev.2025.103841_bb0785","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1093\/hmg\/ddp365","article-title":"Common and different genetic background for rheumatoid arthritis and coeliac disease","volume":"18","author":"Coenen","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb0790","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gene.2010.30","article-title":"The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis","volume":"11","author":"Alcina","year":"2010","journal-title":"Genes Immun"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb0795","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.smim.2004.08.018","article-title":"The SLP-76 family of adapter proteins","volume":"16","author":"Wu","year":"2004","journal-title":"Semin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103841_bb0800","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ng.472","article-title":"Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus","volume":"41","author":"Han","year":"2009","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002004","article-title":"Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci","volume":"7","author":"Zhernakova","year":"2011","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb0810","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1083\/jcb.200811119","article-title":"The RNase Rny1p cleaves tRNAs and promotes cell death during oxidative stress in Saccharomyces cerevisiae","volume":"185","author":"Thompson","year":"2009","journal-title":"J Cell Biol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103841_bb0815","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4161\/cc.8.8.8248","article-title":"The centrosomal FOP protein is required for cell cycle progression and survival","volume":"8","author":"Acquaviva","year":"2009","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.autrev.2025.103841_bb0820","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/rheumatology\/kem096","article-title":"Caspase 7 influences susceptibility to rheumatoid arthritis","volume":"46","author":"Garc\u00eda-Lozano","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2025.103841_bb0825","unstructured":"Hgrxlq LQD, Dplo UDE. Caspase 7 is a potential candidate gene for IDDM17 in a Bedouin Arab family.1:57-60."},{"key":"10.1016\/j.autrev.2025.103841_bb0830","doi-asserted-by":"crossref","first-page":"e009","DOI":"10.1621\/nrs.06009","article-title":"Atrophin proteins an overview of a new class of nuclear receptor corepressors","volume":"6","author":"Wang","year":"2008","journal-title":"Nucl Recept Signal"},{"key":"10.1016\/j.autrev.2025.103841_bb0835","series-title":"Risk of generalized vitiligo is associated with the common 55R-94A-247H variant haplotype of GZMB (encoding granzyme B)","first-page":"1677","author":"Ferrara","year":"2013"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb1000","first-page":"278","article-title":"Epigenetics in human autoimmunity (Epigenetics in autoimmunity-DNA methylation in systemic lupus erythematosus and beyond)","volume":"41","author":"Strickland","year":"2008","journal-title":"Epigenet Syst Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb1005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2230.2006.02233.x","article-title":"Genomic imprinting and dermatological disease","volume":"31","author":"Millington","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb1010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2133.2010.09919.x","article-title":"Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo","volume":"163","author":"Zhao","year":"2010","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb1015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/1346-8138.12725","article-title":"Differential expression analysis of miRNA in peripheral blood mononuclear cells of patients with non-segmental vitiligo","volume":"42","author":"Wang","year":"2015","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb1020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/cdd.2015.117","article-title":"Oxidative stress-induced overexpression of miR-25 the mechanism underlying the degeneration of melanocytes in vitiligo","volume":"23","author":"Shi","year":"2016","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb1025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/jid.2013.310","article-title":"MicroRNA-203 regulates melanosome transport and tyrosinase expression in melanoma cells by targeting kinesin superfamily protein 5b","volume":"134","author":"Noguchi","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103841_bb1030","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1038\/jid.2014.231","article-title":"miR-330-5p targets tyrosinase and induces depigmentation","volume":"134","author":"Rambow","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb1035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/pcmr.12179","article-title":"Novel inhibitory function of miR-125b in melanogenesis","volume":"27","author":"Kim","year":"2014","journal-title":"Pigm. Cell Melanoma Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb1040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/jid.2012.266","article-title":"Identification of miR-145 as a key regulator of the pigmentary process","volume":"133","author":"Dynoodt","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103841_bb1045","first-page":"742","article-title":"MicroRNA-155 is dysregulated in the skin of patients with vitiligo and inhibits melanogenesis-associated genes in melanocytes and keratinocytes","volume":"96","author":"Sahmatova","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb1050","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/bjd.13109","article-title":"MicroRNA profiling reveals differentially expressed microRNA signatures from the skin of patients with nonsegmental vitiligo","volume":"171","author":"Mansuri","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb1055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jdermsci.2016.07.003","article-title":"miRNA signatures and transcriptional regulation of their target genes in vitiligo","volume":"84","author":"Mansuri","year":"2016","journal-title":"J Dermatol Sci"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb1060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/pcmr.12346","article-title":"MicroRNAs in melanocyte and melanoma biology","volume":"28","author":"Mione","year":"2015","journal-title":"Pigm Cell Melanoma Res"},{"issue":"3","key":"10.1016\/j.autrev.2025.103841_bb1065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/pcmr.12081","article-title":"A single-nucleotide polymorphism of miR-196a-2 and vitiligo an association study and functional analysis in a Han Chinese population","volume":"26","author":"Huang","year":"2013","journal-title":"Pigm Cell Melanoma Res"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb1070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s10038-021-00993-z","article-title":"LncRNA-mRNA co-expression network revealing the regulatory roles of lncRNAs in melanogenesis in vitiligo","volume":"67","author":"Pang","year":"2022","journal-title":"J Hum Genet"},{"issue":"5","key":"10.1016\/j.autrev.2025.103841_bb1075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1034\/j.1600-0749.2003.00087.x","article-title":"Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients","volume":"16","author":"Dell\u2019Anna","year":"2003","journal-title":"Pigment Cell Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103841_bb1080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12864-017-3510-3","article-title":"Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets","volume":"18","author":"Dey-Rao","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.autrev.2025.103841_bb1085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.986918","article-title":"Advances in vitiligo: update on therapeutic targets","volume":"13","author":"Feng","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103841_bb1090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5114\/pdia.2014.43497","article-title":"Current aspects of vitiligo genetics","volume":"31","author":"Czajkowski","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103841_bb1100","article-title":"Baricitinib the first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients","volume":"9","author":"Radi","year":"2021","journal-title":"Healthcare (Basel)"},{"issue":"2","key":"10.1016\/j.autrev.2025.103841_bb1105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.det.2016.11.014","article-title":"Vitiligo pathogenesis and emerging treatments","volume":"35","author":"Rashighi","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.autrev.2025.103841_bb1115","article-title":"Pathophysiology of skin resident memory T cells","volume":"11","author":"Tokura","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103841_bb1120","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/jocd.13908","article-title":"Elevated serum level of interleukin-15 in vitiligo patients and its correlation with disease severity but not activity","volume":"20","author":"Atwa","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"450","key":"10.1016\/j.autrev.2025.103841_bb1125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.autrev.2025.103841_bb1130","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/jid.2013.235","article-title":"Wnt\/beta-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation","volume":"133","author":"Yamada","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2025.103841_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105582","article-title":"Design, synthesis and structure-activity relationship optimization of phenanthridine derivatives as new anti-vitiligo compounds","volume":"119","author":"Yang","year":"2022","journal-title":"Bioorg Chem"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:06:55Z","timestamp":1762553215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":222,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1568997225001016"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103841","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and immune dysregulation in vitiligo: Insights into autoimmune mechanisms and disease pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103841"}}